Product Information
BETAXOLOL 20 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.7950 per EA under NDC 10702001401. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jun 27, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702001401
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
BETAXOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078962FDA Approved
6/27/2008
TE Code
AB
On Market Since
11/2/2011
Pharmacological Classes
Price Statistics
The NADAC for BETAXOLOL 20 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7950 per EA |
|---|---|
| All-time high | $1.0818 (Aug 14, 2024) |
| All-time low | $0.7224 (Feb 19, 2025) |
| 52-week high | $0.8257 |
| 52-week low | $0.7950 |
| Median price | $0.7950 |
| Average price | $0.8291 |
| Largest weekly change | -21.5% (Aug 21, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the betaxolol hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
KVK-Tech Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
betaxolol hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAXOLOL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BETAXOLOL 20 MG TABLET, manufactured by KVK-Tech Inc., is $0.7950 per EA (NDC 10702001401), effective Sep 30, 2026.
How has the price of BETAXOLOL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for BETAXOLOL 20 MG TABLET has declined 11.0%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BETAXOLOL 20 MG TABLET?
Since Apr 17, 2024, the NADAC for BETAXOLOL 20 MG TABLET has ranged from a low of $0.7224 (Feb 19, 2025) to a high of $1.0818 (Aug 14, 2024), with a median of $0.7950 per EA.
Are there cheaper alternatives to BETAXOLOL 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BETAXOLOL 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BETAXOLOL 20 MG TABLET?
BETAXOLOL 20 MG TABLET (NDC 10702001401) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.